| Drug Name: | Almotriptan (154323-57-6) |
|---|---|
| PubChem ID: | 123606 |
| SMILES: | CN(C)CCC1=CNC2=C1C=C(C=C2)CS(=O)(=O)N3CCCC3 |
| InchiKey: | WKEMJKQOLOHJLZ-UHFFFAOYSA-N |
| Therapeutic Category: | Neurotransmitter Agents, Serotonin Agents, Serotonin Agonists, Serotonin Receptor Agonists |
| Molecular Weight (dalton) | : | 335.473 |
| LogP | : | 2.1976 |
| Ring Count | : | 2 |
| Hydrogen Bond Acceptor Count | : | 3 |
| Hydrogen Bond Donor Count | : | 1 |
| Total Polar Surface Area | : | 56.41 |
This panel provides information on interacting drugs and their ADRs along with references
| Interacting drug | Toxicity | Interaction Type | Mechanism | Reference |
|---|---|---|---|---|
| verapamil (52-53-9) | Blood Pressure Systolic Increased | Synergistic | verapamil may inhibit the metabolism of almotriptan via the cytochrome P450 isoenzyme CYP3A4 | Pharmacokinetic interaction between verapamil and almotriptan in healthy volunteers |
This panel provides drug-protein interaction and their ADRs along with references
| Toxicity | Interacting Protein | Mechanism | Reference |
|---|
This panel provides drug-food interactions and their ADRs along with references
| Food | Toxicity | Reference |
|---|
This panel provides information on metabolites and their ADRs along with references
| Metabolite | Toxicity | Place of Metabolism | Mechanism | Reference |
|---|
This panel provides information on drug category